Dr Reddys Laboratories Ltd vs Laurus Labs Ltd

A side-by-side comparison of Dr Reddys Laboratories Ltd (DRREDDY) and Laurus Labs Ltd (LAURUSLABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Dr Reddys Laboratories Ltd leads DRREDDY vs LAURUSLABS on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation40
  • Profitability04
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

DRREDDY takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

22.90
P/E ratio
111.79
2.96
P/B ratio
15.69
0.69%
Dividend yield
0.11%
₹50.27
EPS
₹16.46

Profitability

LAURUSLABS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

11.80%
Return on equity
18.30%
14.00%
Return on capital
18.00%
19.00%
EBITDA margin
26.00%
12.34%
Net margin
13.06%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.96%
Revenue CAGR (3Y)
4.09%
-2.65%
Profit CAGR (3Y)
3.92%

Size & financial health

DRREDDY takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹96,318 Cr
Market cap
₹99,417 Cr
₹33,700 Cr
Revenue
₹6,813 Cr
₹4,158 Cr
Net profit
₹890 Cr
0.18
Debt / equity
0.40
Dr Reddys Laboratories Ltd
  • + ["Company's working capital requirements have reduced from 85.1 days to 67.8 days"]
  • ["Dividend payout has been low at 13.2% of profits over last 3 years"]
Laurus Labs Ltd
  • + ["Company has been maintaining a healthy dividend payout of 19.0%"]
  • ["Stock is trading at 18.7 times its book value", "The company has delivered a poor sales growth of 7.19% over past five years.", "Company has a low return on equity of 10.1% over last 3 years.", "Company might be capitalizing the interest cost"]
Dr Reddys Laboratories Ltd full analysis Laurus Labs Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.